Table 1.
Clinical characteristics of patients with capsular warning syndrome
| Tirofiban group N (%) |
Non-tirofiban group N (%) |
|
| Male sex | 11 (73.3) | 6 (75.0) |
| Hypertension | 9 (60) | 5 (62.5) |
| Diabetes mellitus | 0 | 2 (25.0) |
| Hypercholesterolaemia | 11 (73.3) | 6 (75.0) |
| Previous ischaemic stroke | 0 | 0 |
| Ischaemic heart disease | 0 | 0 |
| Atrial fibrillation | 0 | 0 |
| Peripheral vascular disease | 0 | 0 |
| Current alcohol use | 10 (67.7) | 3 (37.5) |
| Smoking | 7 (46.7) | 3 (37.5) |
| Previous antiplatelet therapy | 2 (13.3) | 0 |
| Previous anticoagulant therapy | 0 | 0 |
| Previous antihypertensive therapy | 4 (26.7) | 0 |
| Previous treatment with statins | 2 (13.3) | 0 |
| Previous antiplatelet and statins therapy | 2 (13.3) | 0 |